Prevalence of neuropathic symptoms in diabetic patients evaluated in a specialty outpatient clinic in Alto Vale do Itajaí-SC
DOI:
https://doi.org/10.11606/issn.1679-9836.v104i3e-234727Keywords:
Diabetes mellitus, Diabetic foot, Health promotion, Diabetic neuropathyAbstract
Introduction and objective: Diabetes Mellitus (DM) is a chronic clinical condition that comprising a heterogeneous group of metabolic disorders, whose common characteristic is a persistent hyperglycemic state resulting from defects in insulin secretion or action. Among its main complications there is the diabetic neuropathy, present in 50% of diabetic patients during the course of the disease, with diabetic peripheral neuropathy (DPN) being the most prevalent. This study aimed at describing the DPN prevalence in patients treated at a Brazilian specialty clinic and verifying the odds ratio of possible factors associated to its development. Methods: Patients were evaluated using a questionnaire prepared by the authors, composed by clinical and epidemiological variables, associated to Neuropathic Symptom Score (NSS) and Neuropathic Impairment Score (NIS). The data was analyzed using Statistical Package for the Social sciences (SPSS, version 26.0) and p≤0.05 was considered statistically significant. Results: The sample was composed by 49 patients, with a DPN prevalence of 36.7%. The mean age was 56.2±14.0 years old and the mean diagnosis time was 11.9±8.3 years. There was a predominance of female, Caucasian, married or in a stable union, with incomplete primary education, hypertensive, dyslipidemic and sedentary patients. Conclusion: There was a high DPN prevalence and there were statistically significant associations to marital status and glycemic control, and a higher prevalence of the disease was found among patients with coronary artery disease and smokers. There was conformity between NSS and NIS.
Downloads
References
Harreiter J, Roden M. Diabetes mellitus – definition, klassifikation, diagnose, screening und prävention (update 2019). Wien Klin Wochenschr. 2019;131(Suppl 1):6-15. Doi:10.1007/s00508-019-1450-4
International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Brussels: International Diabetes Federation; 2021. https://www.diabetesatlas.org
Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88-98. Doi:10.1038/nrendo.2017.151
Giacaglia L, Barcellos C, Genestreti P, Silva M, Santos R, Vencio S, et al. Tratamento farmacológico do pré-diabetes. Diretriz Oficial da Sociedade Brasileira de Diabetes. 2022. Doi:10.29327/557753.2022-9. ISBN: 978-65-5941-622-6.
Rolim L, Thyssen P, Flumignan R, Andrade D, Dib S, Bertoluci M. Diagnóstico e tratamento da neuropatia periférica diabética. Diretriz Oficial da Sociedade Brasileira de Diabetes. 2022. Doi:10.29327/557753.2022-14. ISBN: 978-65-5941-622-6.
Samakidou G, Eleftheriadou I, Tentolouris A, Papanas N, Tentolouris N. Rare diabetic neuropathies: it is not only distal symmetrical polyneuropathy. Diabetes Res Clin Pract. 2021;177:108932. Doi: 10.1016/j.diabres.2021.108932
Feldman EL, Callaghan BC, Pop-Busui R, Zochodne DW, Wright DE, Bennett DL, et al. Diabetic neuropathy. Nat Rev Dis Primers. 2019;5:41. Doi:10.1038/s41572-019-0092-1
Jensen TS, Karlsson P, Gylfadottir SS, Andersen ST, Bennett DL, Tankisi H, et al. Painful and non-painful diabetic neuropathy, diagnostic challenges and implications for future management. Brain. 2021;144(6):1757-72. Doi:10.1093/brain/awab079
Izenberg A, Perkins BA, Bril V. Diabetic neuropathies. Semin Neurol. 2015;35(4):346–60. Doi:10.1055/s-0035-1558972.
Cernea S, Raz I. Management of diabetic neuropathy. Metabolism. 2021;123:154867. Doi:10.1016/j.metabol.2021.154867.
Bodman MA, Dreyer MA, Varacallo MA. Diabetic Peripheral Neuropathy. [Updated 2024 Feb 25]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. https://www.ncbi.nlm.nih.gov/books/NBK442009/
Carmichael J, Fadavi H, Ishibashi F, Shore AC, Tavakoli M. Advances in screening, early diagnosis and accurate staging of diabetic neuropathy. Front Endocrinol (Lausanne). 2021;12:671257. Doi:10.3389/fendo.2021.671257.
Moreira RO, Castro AP, Papelbaum M, Appolinário JC, Ellinger VCM, Coutinho WF, et al. Tradução para o português e avaliação da confiabilidade de uma escala para diagnóstico da polineuropatia distal diabética. Arq Bras Endocrinol Metabol. 2005;49(6):983-90. Doi:10.1590/s0004-27302005000600014.
Zakin E, Abrams R, Simpson DM. Diabetic neuropathy. Semin Neurol. 2019;39(5):560-9. Doi:10.1055/s-0039-1688978.
Oh J. Clinical spectrum and diagnosis of diabetic neuropathies. Korean J Intern Med. 2020;35(5):1059-69. Doi:10.3904/kjim.2020.202.
Velasco MB, Rodríguez DC, Montalbán AIR, Jiménez SV, Martínez IFV. Actualización en el diagnóstico, tratamiento y prevención de la neuropatía diabética periférica. Angiología. 2017;69(3):174-81. Doi:10.1016/j.angio.2016.06.005.
Dos Santos HC, Ronsoni MF, Colombo BS, Oliveira CSS, Hohl A, Coral MHC, et al. Peripheral neuropathy scores in diabetic. Rev Soc Bras Clin Med. 2015;13(1):40-5.
Brinati LM, Diogo NAS, Moreira TR, Mendonça ÉT, Amaro MOF. Prevalência e fatores associados à neuropatia periférica em indivíduos com diabetes mellitus. Rev Pesqui Cuid Fundam Online. 2017;9(2):347-55. Doi:10.9789/2175-5361.2017.v9i2.347-355.
Tres GS, Lisbôa HRK, Syllos R, Canani LH, Gross JL. Prevalence and characteristics of diabetic polyneuropathy in Passo Fundo, South of Brazil. Arq Bras Endocrinol Metabol. 2007;51(6):987-92. Doi:10.1590/s0004-27302007000600014.
Ponirakis G, Elhadd T, Al Ozairi E, Brema I, Chinnaiyan S, Taghadom E, et al. Prevalence and risk factors for diabetic peripheral neuropathy, neuropathic pain and foot ulceration in the Arabian Gulf region. J Diabetes Investig. 2022;13(9):1551-9. Doi:10.1111/jdi.13815.
Neto MO, Pereira M da S, Pinto MAH, Agostinho LM, Júnior FER, Hissa MN. Avaliação do autocuidado para a prevenção do pé diabético e exame clínico dos pés em um centro de referência em diabetes mellitus. J Health Biol Sci. 2017;5(3):265-71. Doi:10.12662/2317-3076jhbs.v5i3.1092.
Ibarra RCT, Rocha LJJ, Hernández OR, Nieves RE, Leyva JR. Prevalencia de neuropatía periférica en diabéticos tipo 2 en el primer nivel de atención. Rev Med Chile. 2012;140(9):1126-31. Doi:10.4067/S0034-98872012000900004.
Barrile SR, Ribeiro AA, Costa APR, Viana AA, De Conti MHS, Martinelli B. Sensitive-motor alteration of the lower limbs in diabetics type 2. Fisioter Mov. 2013;26(3):537-48. Doi:10.1590/S0103-51502013000300007.
Rodriguez MM, Guerrero JFR. Importancia del apoyo familiar en el control de la glicemia. Salud Publica Mex. 1997;39(1):44-7.
Otero LM, Zanetti ML, Regina C. Características sociodemográficas e clínicas de portadores de diabetes em um serviço de atenção básica à saúde. Rev Esc Enferm USP. 2007;41(4):768-73. Doi:10.1590/S0104-11692007000700009.
Lechleitner M, Abrahamian H, Francesconi C, Kofler M, Sturm W, Köhler G. Diabetische Neuropathie und diabetischer Fuß (Update 2019). Wien Klin Wochenschr. 2019;131(Suppl 1):S1-S15. Doi:10.1007/s00508-019-1487-4.
Pang L, Lian X, Liu H, Zhang Y, Li Q, Cai Y, et al. Understanding diabetic neuropathy: Focus on oxidative stress. Oxid Med Cell Longev. 2020;2020:9524635. Doi:10.1155/2020/9524635.
Rolim LC, Sá JR, Chacra AR, Dib SA. Heterogeneidade clínica e coexistência das neuropatias diabéticas: diferenças e semelhanças entre diabetes melito tipos 1 e 2. Arq Bras Endocrinol Metabol. 2009;53(7):818-24. Doi:10.1590/s0004-27302009000700005.
Bortoletto MSS, Haddad MCL, Karino ME. Pé diabético, uma avaliação sistematizada. Arq Ciênc Saúde UNIPAR. 2009;13(1):37-43.
Sempere-Bigorra M, Julián-Rochina I, Cauli O. Differences and similarities in neuropathy in type 1 and 2 diabetes: A systematic review. J Pers Med. 2021;11(3):230. Doi:10.3390/jpm11030230.
AlGhamdi G, Saati H, Almotairi E, Alsofiani BS, Kinsara AJ. Peripheral neuropathy as a risk factor for developing cardiovascular disease in diabetic patients. Cureus. 2020;12(12):e11922. Doi:10.7759/cureus.11922.
Henning RJ. Type-2 diabetes mellitus and cardiovascular disease. Future Cardiol. 2018;14(6):491-509. Doi:10.2217/fca-2018-0045.
Nabrdalik K, Kwiendacz H, Moos J, Moos Ł, Kulpa J, Brzoza Z, et al. Diabetic peripheral neuropathy is associated with diabetic kidney disease and cardiovascular disease: The Silesia Diabetes-Heart Project. Curr Probl Cardiol. 2023;48(8):101726. Doi:10.1016/j.cpcardiol.2023.101726.
Soares RL, Ribeiro SMO, Fachin LB, Lima ACTAS, Ramos LO, Ferreira LV. Avaliação de rotina do pé diabético em pacientes internados – prevalência de neuropatia e vasculopatia. HU Rev. 2018;43(3):205-10. Doi:10.34019/1982-8047.2017.v43.2746.
Clair C, Cohen MJ, Eichler F, Selby KJ, Rigotti NA. The effect of cigarette smoking on diabetic peripheral neuropathy: A systematic review and meta-analysis. J Gen Intern Med. 2015;30(8):1193-203. Doi:10.1007/s11606-015-3354-y.
Ministério da Saúde, Secretaria de Vigilância em Saúde, Departamento de Análise em Saúde e Vigilância de Doenças não Transmissíveis. Vigitel Brasil 2019: vigilância de fatores de risco e proteção para doenças crônicas por inquérito telefônico: estimativas sobre frequência e distribuição sociodemográfica de fatores de risco e proteção para doenças crônicas nas capitais dos 26 estados brasileiros e no Distrito Federal em 2019 [Internet]. Brasília: Ministério da Saúde; 2020.
Callaghan BC, Price RS, Feldman EL. Distal symmetric polyneuropathy: A review. JAMA. 2015;314(20):2172-81. Doi:10.1001/jama.2015.13611.
Departamento de Atenção Básica. Estratégias para o cuidado da pessoa com doença crônica. Diabetes mellitus. Brasília (DF): Ministério da Saúde; 2013.
International Diabetes Federation. Clinical practice recommendation on the diabetic foot: A guide for health care professionals. Brussels: International Diabetes Federation; 2017.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Brenda Menegaro Wilhelms, Ana Luiza Andrade Zeferino, Eduardo Beduschi Voelz
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
